Work

Combined treatment with the checkpoint abrogator UCN-01 and MEK1/2 inhibitors potently induces apoptosis in drug-sensitive and -resistant myeloma cells through an IL-6–independent mechanism

Year: 2002

Type: article

Source: Blood

DOI: 10.1182/blood-2002-03-0940

Authors: Yun Dai, Terry H. Landowski, Steven T. Rosen, Paul Dent, Steven Grant

Institutions: University of Arizona, Virginia Commonwealth University, Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Virginia Commonwealth University Medical Center

Language: English

Topic: Multiple Myeloma Research and Treatments

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: National Institutes of Health, National Cancer Institute, National Institute of Diabetes and Digestive and Kidney Diseases

Awards: G1191033322, G1685919197, POTENTIATION OF TAXANE ACTIVITY BY MEK/MAPK INHIBITORS, G2585495816, Carcinoma cell radiosensitization by MAPK inhibition, Promotion of Nucleoside Analog Induced Apoptosis by HDIs, COMPLEMENT AND THE COMPLICATIONS OF DIABETES, G890863337

OpenAlex ID: W2063631973

FWCI: 3.9

Cites: 58

Cited by: 94

Related to: 10